Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Anagliptin or Sitagliptin are effective in
reducing the low-density lipoprotein cholesterol in patients with type 2 diabetes and
cardiovascular risk factors on statin.